Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
DNA Methylation | 17 | 2023 | 628 | 1.890 |
Why?
|
Proto-Oncogene Proteins | 9 | 2023 | 645 | 0.850 |
Why?
|
Herpesvirus 4, Human | 5 | 2023 | 114 | 0.770 |
Why?
|
Cytosine | 5 | 2015 | 127 | 0.710 |
Why?
|
Restriction Mapping | 2 | 2018 | 157 | 0.700 |
Why?
|
Oncogene Proteins, Fusion | 8 | 2023 | 128 | 0.700 |
Why?
|
Epigenesis, Genetic | 10 | 2023 | 479 | 0.580 |
Why?
|
Sequence Analysis, DNA | 3 | 2018 | 853 | 0.570 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2018 | 456 | 0.570 |
Why?
|
DNA-Binding Proteins | 8 | 2023 | 1208 | 0.570 |
Why?
|
Poly (ADP-Ribose) Polymerase-1 | 3 | 2022 | 21 | 0.550 |
Why?
|
CpG Islands | 10 | 2023 | 151 | 0.530 |
Why?
|
Mixed Function Oxygenases | 5 | 2023 | 68 | 0.530 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 8 | 2018 | 375 | 0.510 |
Why?
|
Erythroid Cells | 1 | 2013 | 14 | 0.480 |
Why?
|
Epstein-Barr Virus Infections | 3 | 2023 | 50 | 0.480 |
Why?
|
Erythropoiesis | 1 | 2013 | 52 | 0.470 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 10 | 2023 | 52 | 0.470 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2013 | 148 | 0.450 |
Why?
|
Hematologic Neoplasms | 2 | 2014 | 329 | 0.440 |
Why?
|
Colonic Neoplasms | 3 | 2023 | 556 | 0.420 |
Why?
|
Leukemia | 4 | 2023 | 320 | 0.410 |
Why?
|
Dioxygenases | 5 | 2021 | 74 | 0.400 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2018 | 1197 | 0.370 |
Why?
|
Embryonic Stem Cells | 3 | 2019 | 78 | 0.360 |
Why?
|
Virus Latency | 4 | 2023 | 33 | 0.320 |
Why?
|
5-Methylcytosine | 5 | 2015 | 112 | 0.300 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2024 | 262 | 0.300 |
Why?
|
Genome, Viral | 3 | 2022 | 74 | 0.300 |
Why?
|
Aging | 3 | 2023 | 691 | 0.290 |
Why?
|
Chromatin | 4 | 2023 | 380 | 0.290 |
Why?
|
Mutation | 7 | 2021 | 3968 | 0.280 |
Why?
|
CCCTC-Binding Factor | 3 | 2023 | 18 | 0.280 |
Why?
|
Neoplasm, Residual | 3 | 2005 | 162 | 0.280 |
Why?
|
Cell Line, Tumor | 11 | 2021 | 2426 | 0.280 |
Why?
|
Humans | 45 | 2024 | 86643 | 0.270 |
Why?
|
Colorectal Neoplasms | 2 | 2023 | 938 | 0.260 |
Why?
|
RNA | 4 | 2024 | 560 | 0.250 |
Why?
|
Transcription Factors | 6 | 2024 | 1565 | 0.240 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2019 | 623 | 0.240 |
Why?
|
Histone Deacetylase Inhibitors | 3 | 2016 | 85 | 0.230 |
Why?
|
Animals | 18 | 2024 | 26582 | 0.230 |
Why?
|
Mice | 12 | 2024 | 11352 | 0.220 |
Why?
|
Drug Overdose | 1 | 2023 | 65 | 0.220 |
Why?
|
Programmed Cell Death 1 Receptor | 1 | 2024 | 159 | 0.220 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 2023 | 102 | 0.210 |
Why?
|
Adenocarcinoma | 2 | 2023 | 1169 | 0.210 |
Why?
|
Paraganglioma | 1 | 2022 | 16 | 0.210 |
Why?
|
Pheochromocytoma | 1 | 2022 | 49 | 0.200 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2023 | 164 | 0.200 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2022 | 58 | 0.200 |
Why?
|
Graft vs Host Disease | 1 | 2024 | 365 | 0.200 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2022 | 80 | 0.200 |
Why?
|
Neuroendocrine Tumors | 1 | 2023 | 105 | 0.200 |
Why?
|
Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2021 | 72 | 0.190 |
Why?
|
Opioid-Related Disorders | 1 | 2023 | 161 | 0.190 |
Why?
|
Adenoma | 1 | 2023 | 235 | 0.190 |
Why?
|
Transcriptome | 2 | 2022 | 580 | 0.190 |
Why?
|
Antineoplastic Agents | 3 | 2023 | 2360 | 0.190 |
Why?
|
Carcinogenesis | 2 | 2023 | 195 | 0.190 |
Why?
|
Stomach Neoplasms | 1 | 2023 | 266 | 0.190 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2018 | 763 | 0.180 |
Why?
|
WT1 Proteins | 2 | 2014 | 19 | 0.180 |
Why?
|
Transcription, Genetic | 4 | 2022 | 1135 | 0.180 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2018 | 151 | 0.180 |
Why?
|
DNA Primers | 2 | 2016 | 543 | 0.180 |
Why?
|
Esophageal Neoplasms | 1 | 2022 | 321 | 0.170 |
Why?
|
Azacitidine | 2 | 2023 | 137 | 0.170 |
Why?
|
Gene Expression | 3 | 2022 | 1284 | 0.170 |
Why?
|
Breast | 1 | 2021 | 288 | 0.170 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2023 | 383 | 0.170 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 388 | 0.170 |
Why?
|
DNA Repair | 1 | 2021 | 356 | 0.170 |
Why?
|
Viral Matrix Proteins | 1 | 2018 | 14 | 0.170 |
Why?
|
Cyclin-Dependent Kinase 9 | 1 | 2018 | 6 | 0.170 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2011 | 879 | 0.170 |
Why?
|
Sex Characteristics | 2 | 2019 | 319 | 0.170 |
Why?
|
Chromosome Mapping | 1 | 2022 | 1074 | 0.170 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2018 | 42 | 0.160 |
Why?
|
Ganglia, Spinal | 1 | 2018 | 72 | 0.160 |
Why?
|
Neuralgia | 1 | 2018 | 28 | 0.160 |
Why?
|
Oncogenes | 1 | 2018 | 88 | 0.160 |
Why?
|
Caloric Restriction | 1 | 2017 | 14 | 0.160 |
Why?
|
Enhancer of Zeste Homolog 2 Protein | 1 | 2017 | 35 | 0.160 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 2 | 2015 | 21 | 0.160 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 592 | 0.150 |
Why?
|
Microbiota | 1 | 2022 | 381 | 0.150 |
Why?
|
Pancreatic Neoplasms | 1 | 2023 | 645 | 0.150 |
Why?
|
Sex Chromosomes | 1 | 2017 | 57 | 0.150 |
Why?
|
DNA Modification Methylases | 1 | 2016 | 25 | 0.150 |
Why?
|
Immunologic Memory | 1 | 2017 | 152 | 0.140 |
Why?
|
Heart | 1 | 2019 | 539 | 0.140 |
Why?
|
Enhancer Elements, Genetic | 2 | 2015 | 266 | 0.140 |
Why?
|
Neoplasms, Experimental | 1 | 2017 | 269 | 0.140 |
Why?
|
Triple Negative Breast Neoplasms | 1 | 2018 | 137 | 0.140 |
Why?
|
Chronic Pain | 1 | 2018 | 145 | 0.140 |
Why?
|
Binding Sites | 4 | 2023 | 1098 | 0.130 |
Why?
|
Leukemia, Myeloid | 3 | 2010 | 249 | 0.130 |
Why?
|
Gene Expression Regulation, Viral | 3 | 2022 | 90 | 0.130 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2023 | 427 | 0.130 |
Why?
|
Up-Regulation | 5 | 2018 | 712 | 0.130 |
Why?
|
Macaca mulatta | 1 | 2017 | 459 | 0.130 |
Why?
|
Hydroxamic Acids | 1 | 2014 | 49 | 0.130 |
Why?
|
RNA Interference | 2 | 2018 | 369 | 0.130 |
Why?
|
DNA | 4 | 2023 | 1294 | 0.120 |
Why?
|
Signal Transduction | 3 | 2022 | 3241 | 0.120 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 547 | 0.120 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2017 | 559 | 0.120 |
Why?
|
DNA Mutational Analysis | 2 | 2012 | 526 | 0.120 |
Why?
|
Mutation, Missense | 1 | 2015 | 276 | 0.120 |
Why?
|
Enzyme Inhibitors | 1 | 2016 | 639 | 0.120 |
Why?
|
Antigens, CD34 | 1 | 2013 | 158 | 0.120 |
Why?
|
Promoter Regions, Genetic | 4 | 2018 | 937 | 0.110 |
Why?
|
Blood Donors | 1 | 2012 | 26 | 0.110 |
Why?
|
Sulfonamides | 1 | 2014 | 300 | 0.110 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2013 | 51 | 0.110 |
Why?
|
Colon | 1 | 2015 | 496 | 0.110 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2015 | 90 | 0.100 |
Why?
|
Histones | 1 | 2013 | 311 | 0.100 |
Why?
|
Thrombocytopenia | 1 | 2012 | 183 | 0.100 |
Why?
|
Hematopoietic Stem Cells | 2 | 2011 | 292 | 0.100 |
Why?
|
Mice, Inbred NOD | 2 | 2024 | 187 | 0.100 |
Why?
|
Mice, Inbred C57BL | 4 | 2018 | 3092 | 0.100 |
Why?
|
Myeloid Cells | 1 | 2011 | 98 | 0.100 |
Why?
|
Blood Platelet Disorders | 1 | 2010 | 9 | 0.100 |
Why?
|
Male | 13 | 2019 | 40965 | 0.100 |
Why?
|
Child, Preschool | 6 | 2017 | 3612 | 0.100 |
Why?
|
Neuroblastoma | 1 | 2014 | 374 | 0.090 |
Why?
|
Female | 13 | 2021 | 44532 | 0.090 |
Why?
|
Phthalazines | 2 | 2022 | 39 | 0.090 |
Why?
|
Phenotype | 3 | 2023 | 2378 | 0.090 |
Why?
|
Infant, Newborn | 4 | 2017 | 2379 | 0.090 |
Why?
|
Myelodysplastic Syndromes | 1 | 2012 | 346 | 0.090 |
Why?
|
Cell Cycle | 3 | 2010 | 502 | 0.090 |
Why?
|
Cell Line | 3 | 2019 | 2468 | 0.090 |
Why?
|
Hematopoiesis | 3 | 2015 | 163 | 0.080 |
Why?
|
Piperazines | 2 | 2022 | 272 | 0.080 |
Why?
|
Cells, Cultured | 1 | 2013 | 2818 | 0.080 |
Why?
|
Infant | 4 | 2017 | 3046 | 0.080 |
Why?
|
Cell Survival | 1 | 2010 | 969 | 0.080 |
Why?
|
Host-Pathogen Interactions | 2 | 2022 | 231 | 0.080 |
Why?
|
Child | 7 | 2017 | 6927 | 0.080 |
Why?
|
B-Lymphocytes | 3 | 2022 | 724 | 0.080 |
Why?
|
RUNX1 Translocation Partner 1 Protein | 2 | 2023 | 8 | 0.080 |
Why?
|
Breast Neoplasms | 1 | 2021 | 2903 | 0.080 |
Why?
|
Leukemia, Lymphoid | 1 | 2007 | 72 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2007 | 25 | 0.070 |
Why?
|
Polymerase Chain Reaction | 3 | 2006 | 927 | 0.070 |
Why?
|
Lymphopoiesis | 1 | 2007 | 48 | 0.070 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 2006 | 20 | 0.070 |
Why?
|
RNA, Neoplasm | 2 | 2004 | 87 | 0.070 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 1 | 2006 | 37 | 0.070 |
Why?
|
Biomarkers, Tumor | 2 | 2022 | 1464 | 0.070 |
Why?
|
Fetal Blood | 1 | 2006 | 90 | 0.070 |
Why?
|
Gene Expression Regulation | 3 | 2022 | 1920 | 0.070 |
Why?
|
Mice, Transgenic | 2 | 2021 | 1540 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2012 | 878 | 0.070 |
Why?
|
DNA, Neoplasm | 1 | 2006 | 265 | 0.070 |
Why?
|
Protein Binding | 2 | 2022 | 1456 | 0.060 |
Why?
|
RNA, Messenger | 3 | 2011 | 1981 | 0.060 |
Why?
|
Aspartate-Ammonia Ligase | 1 | 2004 | 2 | 0.060 |
Why?
|
Cell Adhesion Molecules | 1 | 2005 | 163 | 0.060 |
Why?
|
Receptors, Immunologic | 1 | 2005 | 135 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2021 | 1961 | 0.060 |
Why?
|
Asparaginase | 1 | 2004 | 35 | 0.060 |
Why?
|
Gene Expression Profiling | 3 | 2017 | 1384 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2007 | 403 | 0.060 |
Why?
|
Nuclear Proteins | 2 | 2018 | 696 | 0.060 |
Why?
|
Naloxone | 1 | 2023 | 59 | 0.060 |
Why?
|
Disease-Free Survival | 2 | 2005 | 1204 | 0.060 |
Why?
|
Fentanyl | 1 | 2023 | 65 | 0.060 |
Why?
|
Ribonucleotides | 1 | 2023 | 13 | 0.060 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2023 | 13 | 0.060 |
Why?
|
Mice, SCID | 1 | 2024 | 252 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-abl | 1 | 2023 | 30 | 0.060 |
Why?
|
Antigens, CD | 1 | 2005 | 458 | 0.060 |
Why?
|
Entropy | 1 | 2023 | 38 | 0.060 |
Why?
|
Acute Disease | 3 | 2012 | 826 | 0.060 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2003 | 54 | 0.060 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2003 | 65 | 0.060 |
Why?
|
Cell Proliferation | 3 | 2018 | 1578 | 0.060 |
Why?
|
Oligonucleotides | 1 | 2023 | 92 | 0.050 |
Why?
|
Mucous Membrane | 1 | 2022 | 83 | 0.050 |
Why?
|
fms-Like Tyrosine Kinase 3 | 2 | 2018 | 127 | 0.050 |
Why?
|
Nuclear Lamina | 1 | 2022 | 7 | 0.050 |
Why?
|
Neoplasms | 1 | 2017 | 2898 | 0.050 |
Why?
|
Lamin Type A | 1 | 2022 | 24 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2018 | 6509 | 0.050 |
Why?
|
Translocation, Genetic | 1 | 2003 | 265 | 0.050 |
Why?
|
Esophagus | 1 | 2022 | 102 | 0.050 |
Why?
|
Genome, Human | 2 | 2018 | 756 | 0.050 |
Why?
|
Methyltransferases | 1 | 2023 | 182 | 0.050 |
Why?
|
Mice, Knockout | 2 | 2017 | 1924 | 0.050 |
Why?
|
B7-H1 Antigen | 1 | 2023 | 250 | 0.050 |
Why?
|
Plasmids | 1 | 2022 | 287 | 0.050 |
Why?
|
Epithelium | 1 | 2022 | 319 | 0.050 |
Why?
|
Blotting, Western | 2 | 2017 | 782 | 0.050 |
Why?
|
CRISPR-Cas Systems | 1 | 2021 | 70 | 0.050 |
Why?
|
Single-Cell Analysis | 1 | 2022 | 134 | 0.050 |
Why?
|
Ligands | 1 | 2022 | 433 | 0.050 |
Why?
|
Gene Knockdown Techniques | 1 | 2021 | 236 | 0.050 |
Why?
|
Stem Cells | 1 | 2023 | 351 | 0.050 |
Why?
|
Genotype | 2 | 2021 | 1851 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 1313 | 0.050 |
Why?
|
Adolescent | 3 | 2017 | 8981 | 0.050 |
Why?
|
Neoplastic Stem Cells | 1 | 2021 | 143 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2021 | 458 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2022 | 379 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2015 | 1805 | 0.040 |
Why?
|
Analgesics, Opioid | 1 | 2023 | 413 | 0.040 |
Why?
|
Cell Differentiation | 2 | 2015 | 1458 | 0.040 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 418 | 0.040 |
Why?
|
Clone Cells | 2 | 2010 | 213 | 0.040 |
Why?
|
Small Molecule Libraries | 1 | 2018 | 61 | 0.040 |
Why?
|
Prognosis | 3 | 2018 | 3679 | 0.040 |
Why?
|
DNA Helicases | 1 | 2018 | 79 | 0.040 |
Why?
|
DNA Restriction Enzymes | 1 | 2018 | 98 | 0.040 |
Why?
|
Genomic Library | 1 | 2018 | 33 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2018 | 120 | 0.040 |
Why?
|
Prospective Studies | 2 | 2005 | 4213 | 0.040 |
Why?
|
DNA (Cytosine-5-)-Methyltransferases | 1 | 2018 | 55 | 0.040 |
Why?
|
Epithelial Cells | 1 | 2022 | 669 | 0.040 |
Why?
|
Genomics | 1 | 2023 | 720 | 0.040 |
Why?
|
Structure-Activity Relationship | 1 | 2018 | 408 | 0.040 |
Why?
|
K562 Cells | 1 | 2017 | 43 | 0.040 |
Why?
|
Epigenomics | 1 | 2018 | 100 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 1 | 2018 | 196 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2018 | 280 | 0.040 |
Why?
|
Cohort Studies | 3 | 2012 | 2767 | 0.040 |
Why?
|
Longevity | 1 | 2017 | 51 | 0.040 |
Why?
|
Pandemics | 1 | 2023 | 740 | 0.040 |
Why?
|
MCF-7 Cells | 1 | 2017 | 106 | 0.040 |
Why?
|
Models, Molecular | 1 | 2022 | 1286 | 0.040 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2018 | 182 | 0.040 |
Why?
|
Histone Demethylases | 1 | 2016 | 30 | 0.040 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 296 | 0.040 |
Why?
|
Myocytes, Cardiac | 1 | 2019 | 275 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2017 | 270 | 0.040 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2016 | 133 | 0.040 |
Why?
|
HeLa Cells | 1 | 2017 | 498 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2017 | 322 | 0.030 |
Why?
|
Drug Synergism | 1 | 2016 | 303 | 0.030 |
Why?
|
Genetic Loci | 1 | 2017 | 250 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2003 | 3640 | 0.030 |
Why?
|
Aged | 3 | 2018 | 18415 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2017 | 615 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 1 | 2018 | 1219 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 246 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2015 | 96 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2022 | 1196 | 0.030 |
Why?
|
ErbB Receptors | 1 | 2018 | 485 | 0.030 |
Why?
|
Phosphorylation | 1 | 2017 | 1106 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2014 | 24 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2014 | 74 | 0.030 |
Why?
|
Immunophenotyping | 2 | 2005 | 211 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2021 | 2232 | 0.030 |
Why?
|
Immunoglobulins | 2 | 2005 | 148 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 589 | 0.030 |
Why?
|
Models, Biological | 1 | 2021 | 1749 | 0.030 |
Why?
|
Response Elements | 1 | 2014 | 63 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2014 | 270 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 2007 | 1041 | 0.030 |
Why?
|
Middle Aged | 3 | 2018 | 25028 | 0.030 |
Why?
|
Cell Hypoxia | 1 | 2014 | 164 | 0.030 |
Why?
|
Adult | 3 | 2018 | 25648 | 0.030 |
Why?
|
Blood Grouping and Crossmatching | 1 | 2012 | 14 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2005 | 372 | 0.030 |
Why?
|
Telomerase | 1 | 2012 | 55 | 0.030 |
Why?
|
Recurrence | 2 | 2005 | 1139 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2005 | 679 | 0.030 |
Why?
|
Rats | 1 | 2018 | 3990 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2011 | 77 | 0.020 |
Why?
|
United States | 1 | 2023 | 6672 | 0.020 |
Why?
|
Family | 1 | 2012 | 311 | 0.020 |
Why?
|
Haploinsufficiency | 1 | 2011 | 62 | 0.020 |
Why?
|
Gene Silencing | 1 | 2011 | 172 | 0.020 |
Why?
|
Codon, Nonsense | 1 | 2010 | 41 | 0.020 |
Why?
|
Family Health | 1 | 2010 | 162 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2003 | 7993 | 0.020 |
Why?
|
Gene Deletion | 1 | 2011 | 329 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2011 | 348 | 0.020 |
Why?
|
Exons | 1 | 2010 | 450 | 0.020 |
Why?
|
Pedigree | 1 | 2010 | 966 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2010 | 329 | 0.020 |
Why?
|
Alleles | 1 | 2011 | 1128 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2002 | 1991 | 0.020 |
Why?
|
Granzymes | 1 | 2007 | 93 | 0.020 |
Why?
|
Base Sequence | 1 | 2010 | 2330 | 0.020 |
Why?
|
Tandem Repeat Sequences | 1 | 2006 | 26 | 0.020 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2006 | 72 | 0.020 |
Why?
|
Czech Republic | 1 | 2005 | 3 | 0.020 |
Why?
|
CD13 Antigens | 1 | 2005 | 5 | 0.020 |
Why?
|
Sialic Acid Binding Ig-like Lectin 3 | 1 | 2005 | 8 | 0.020 |
Why?
|
Lewis X Antigen | 1 | 2005 | 9 | 0.020 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2005 | 32 | 0.020 |
Why?
|
Neonatal Screening | 1 | 2006 | 59 | 0.020 |
Why?
|
Gene Duplication | 1 | 2006 | 125 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2005 | 50 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2006 | 253 | 0.020 |
Why?
|
Neprilysin | 1 | 2005 | 42 | 0.020 |
Why?
|
Glycosylation | 1 | 2005 | 129 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 2438 | 0.020 |
Why?
|
Cytoplasm | 1 | 2005 | 281 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2005 | 170 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 2271 | 0.010 |
Why?
|
Air Movements | 1 | 2002 | 2 | 0.010 |
Why?
|
beta 2-Microglobulin | 1 | 2002 | 24 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2006 | 532 | 0.010 |
Why?
|
Equipment Failure Analysis | 1 | 2002 | 90 | 0.010 |
Why?
|
Quality Control | 1 | 2002 | 117 | 0.010 |
Why?
|
Bone Marrow | 1 | 2004 | 435 | 0.010 |
Why?
|
Cell Membrane | 1 | 2005 | 666 | 0.010 |
Why?
|
Temperature | 1 | 2002 | 396 | 0.010 |
Why?
|
Apoptosis | 1 | 2007 | 1683 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2002 | 381 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2002 | 1673 | 0.010 |
Why?
|
Time Factors | 1 | 2005 | 5210 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2002 | 2705 | 0.010 |
Why?
|